002728 logo

Teyi Pharmaceutical Group Co.,Ltd Stock Price

SZSE:002728 Community·CN¥6.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002728 Share Price Performance

CN¥13.05
3.72 (39.87%)
CN¥13.05
3.72 (39.87%)
Price CN¥13.05

002728 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with high growth potential.

1 Risk
2 Rewards

Teyi Pharmaceutical Group Co.,Ltd Key Details

CN¥924.0m

Revenue

CN¥405.7m

Cost of Revenue

CN¥518.3m

Gross Profit

CN¥438.6m

Other Expenses

CN¥79.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.16
56.09%
8.63%
14.4%
View Full Analysis

About 002728

Founded
2002
Employees
1341
CEO
n/a
WebsiteView website
www.tczy.com.cn

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patent medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company provides cough and phlegm, kidney, anti- infection, cardiovascular and cerebrovascular, and digestive system drugs, as well as pediatrics, dermatology, tuberculosis, respiratory, rheumatology, nephrology, and endocrinology medicines. Its chemical raw materials and products include aluminum carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc.The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. Teyi Pharmaceutical Group Co.,Ltd was founded in 2002 and is based in Taishan City, the People’s Republic of China.

Recent 002728 News & Updates

Recent updates

No updates